PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Short Interest Down 16.6% in March

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) saw a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 25,100 shares, a decrease of 16.6% from the March 15th total of 30,100 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 29,300 shares, the short-interest ratio is currently 0.9 days.

PreveCeutical Medical Price Performance

PRVCF opened at $0.02 on Wednesday. The business has a 50 day simple moving average of $0.02 and a 200-day simple moving average of $0.02. PreveCeutical Medical has a 12 month low of $0.01 and a 12 month high of $0.03.

About PreveCeutical Medical

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.